https://www.healthbulletinhaiti.com/article/909355749-psychemedics-releases-2026-workforce-insights-report Health Bulletin Haiti en PressRelease 2026-04-30T14:00:00+00:00 Psychemedics Releases 2026 Workforce Insights Report https://ml.globenewswire.com/media/b2b4d705-cbfa-4454-b34d-791c4cc1a95d/small/psychemdicslogo-jpg.jpg https://www.healthbulletinhaiti.com/article/909355767-willow-glow-wellness-spa-clinics-announces-advanced-led-facelift-protocol-attracting-silicon-valley-clients-for-non-surgical-skin-rejuvenation Health Bulletin Haiti en PressRelease 2026-04-30T14:00:00+00:00 Willow Glow Wellness Spa Clinics Announces Advanced LED Facelift Protocol, Attracting Silicon Valley Clients for Non-Surgical Skin Rejuvenation https://pressranger.s3.us-west-1.amazonaws.com/3236534/Willow-Glow-Wellness-Spa-Clinics.jpg https://www.healthbulletinhaiti.com/article/909355790-youthcommerce-unveils-phiflow-a-revolutionary-operating-standard-for-clinics Health Bulletin Haiti en PressRelease 2026-04-30T14:00:00+00:00 YouthCommerce Unveils PhiFlow: A Revolutionary Operating Standard for Clinics https://pressranger.s3.us-west-1.amazonaws.com/3238461/WhatsApp-Image-2026-04-30-at-00.27.26-%281%29.jpeg https://www.healthbulletinhaiti.com/article/909351300-health-catalyst-appoints-steve-nelson-president-of-aetna-to-its-board-of-directors Health Bulletin Haiti en PressRelease 2026-04-30T13:27:50+00:00 Health Catalyst Appoints Steve Nelson, President of Aetna, to Its Board of Directors https://ml.globenewswire.com/media/95973775-03d2-4696-b65c-c43ff730af3a/small/picture1-jpg.jpg https://www.healthbulletinhaiti.com/article/909350993-kraig-labs-clears-dual-commercialization-milestones-with-record-spider-silk-production-and-successful-reeling-operations Health Bulletin Haiti en PressRelease 2026-04-30T13:20:00+00:00 Kraig Labs Clears Dual Commercialization Milestones with Record Spider Silk Production and Successful Reeling Operations https://ml.globenewswire.com/media/528d80d7-f9ef-40f6-809b-ba259822f33a/medium/some-of-kraig-labs-recently-reeled-recombinant-spider-silk.PNG https://www.healthbulletinhaiti.com/article/909346018-myriad-genetics-national-survey-88-of-patients-with-depression-and-or-anxiety-would-feel-more-confident-with-a-personalized-mental-health-care-plan Health Bulletin Haiti en PressRelease 2026-04-30T13:05:00+00:00 Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.healthbulletinhaiti.com/article/909346053-former-stryker-medical-division-president-brad-saar-joins-sonablate-board-to-support-growth-of-non-invasive-prostate-cancer-treatment Health Bulletin Haiti en PressRelease 2026-04-30T13:03:00+00:00 Former Stryker Medical Division President Brad Saar Joins Sonablate Board to Support Growth of Non-Invasive Prostate Cancer Treatment https://ml.globenewswire.com/media/dc6636f6-7b53-461a-9684-b8391c5ca4b0/small/sonablate-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909345937-vivus-announces-qsiva-price-reduction-across-nordics-and-poland Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 VIVUS Announces QSIVA® Price Reduction Across Nordics and Poland https://ml-eu.globenewswire.com/media/900f9144-8898-470f-b890-333d03292228/small/vivus-wordmark-blue-400x130-2x-rgb-png.png https://www.healthbulletinhaiti.com/article/909345945-vivus-og-asza-obni-k-ceny-produktu-qsiva-w-krajach-nordyckich-i-w-polsce Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 VIVUS ogłasza obniżkę ceny produktu QSIVA® w krajach nordyckich i w Polsce https://ml-eu.globenewswire.com/media/900f9144-8898-470f-b890-333d03292228/small/ https://www.healthbulletinhaiti.com/article/909346005-new-york-blood-center-enterprises-and-biohub-launch-collaboration-to-advance-cord-blood-derived-stem-cell-platforms Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 New York Blood Center Enterprises and Biohub Launch Collaboration to Advance Cord Blood–Derived Stem Cell Platforms https://ml.globenewswire.com/media/bd7263c3-72fd-4933-8d98-a18a581f0a6e/small/nybce-logo-2-color-jpg.jpg https://www.healthbulletinhaiti.com/article/909346076-glucotrack-announces-publication-of-peer-reviewed-study-in-the-journal-of-diabetes-research-demonstrating-long-term-accuracy-and-stability-of Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 Glucotrack Announces Publication of Peer-Reviewed Study In The Journal of Diabetes Research Demonstrating Long-Term Accuracy and Stability of Continuous Blood Glucose Monitoring Technology https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://www.healthbulletinhaiti.com/article/909346093-a-d-a-m-innovations-enables-pharmacogenomics-for-ntt-precision-medicine Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine https://ml.globenewswire.com/media/57b381e4-7649-49a9-bf54-e247c5a8cf1f/small/adam-innovations-horizontal-png.png https://www.healthbulletinhaiti.com/article/909346289-fate-therapeutics-announces-data-presentation-of-ft819-off-the-shelf-car-t-cell-product-candidate-for-systemic-lupus-erythematosus-sle-at-the-ccr Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 Fate Therapeutics Announces Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Lupus Erythematosus (SLE) at the CCR – East 2026 Meeting https://ml.globenewswire.com/media/2acb7cd9-5f5c-42d0-a606-72d085e2fe6e/small/fate-therapeutics-jpg.jpg https://www.healthbulletinhaiti.com/article/909346313-alkeus-pharmaceuticals-announces-presentation-of-gildeuretinol-data-during-the-association-for-research-in-vision-and-ophthalmology-arvo-2026-annual Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 Alkeus Pharmaceuticals Announces Presentation of Gildeuretinol Data During the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting https://ml.globenewswire.com/media/fd46716f-cd58-41ed-99f3-9c111a393d15/small/alkeus-pharma-logo-2024-png.png https://www.healthbulletinhaiti.com/article/909346358-precision-neuroscience-partners-with-uchicago-medicine-researchers-to-advance-brain-computer-interface-research Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 Precision Neuroscience™ Partners With UChicago Medicine Researchers to Advance Brain–Computer Interface Research https://ml.globenewswire.com/media/30f132af-7046-4849-993d-ae830a076476/small/pn-logo-jpg.png https://www.healthbulletinhaiti.com/article/909346394-fda-grants-orchestra-biomed-additional-breakthrough-device-designation-for-avim-therapy Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy https://ml.globenewswire.com/media/00697d05-bd34-4570-822b-f204caf21694/small/ogsk2sgeyptxenjnnf5a-png.png https://www.healthbulletinhaiti.com/article/909346422-ernexa-therapeutics-announces-1-for-25-reverse-stock-split Health Bulletin Haiti en PressRelease 2026-04-30T13:00:00+00:00 Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split https://ml.globenewswire.com/media/bb12f9ec-b7e7-4d8c-92df-cf27e238c398/small/ernexa-color-png.png https://www.healthbulletinhaiti.com/article/909346243-avita-medical-names-cary-vance-as-chief-executive-officer Health Bulletin Haiti en PressRelease 2026-04-30T12:50:00+00:00 AVITA Medical Names Cary Vance as Chief Executive Officer https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.healthbulletinhaiti.com/article/909341318-can-fite-reports-positive-phase-2a-data-with-namodenoson-in-pancreatic-cancer-35-of-patients-remain-on-therapy-including-one-beyond-16-months Health Bulletin Haiti en PressRelease 2026-04-30T12:31:35+00:00 Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months https://ml.globenewswire.com/media/ca5e71b0-5c40-4d54-96ce-7ce704201c96/small/can-fite-biopharma-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909340879-teva-s-2025-healthy-future-report-highlights-environmental-and-access-to-medicines-progress-including-meeting-all-sustainability-linked-bond-targets Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.healthbulletinhaiti.com/article/909340880-vvt-med-announces-positive-clinical-data-for-sclerosafe-r-published-in-peer-reviewed-indian-journal-of-vascular-and-endovascular-surgery Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 VVT Med Announces Positive Clinical Data for ScleroSafe(R) Published in Peer-Reviewed Indian Journal of Vascular and Endovascular Surgery https://ml-eu.globenewswire.com/media/7ee51e55-03a5-402b-887f-1c43066d7063/small/logo-303-png.png https://www.healthbulletinhaiti.com/article/909340890-edap-tms-strengthens-market-position-with-landmark-hifi-2-data-supporting-focal-one-robotic-hifu-in-radiorecurrent-prostate-cancer Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 EDAP TMS Strengthens Market Position with Landmark HIFI-2 Data Supporting Focal One® Robotic HIFU in Radiorecurrent Prostate Cancer https://ml-eu.globenewswire.com/media/ded19329-9645-4860-ac2d-bf3e2422b649/small/focalone-square-logo-drkblue-web-400-1-png.png https://www.healthbulletinhaiti.com/article/909341001-kriya-announces-presentations-at-asgct-2026-highlighting-advances-across-gene-therapy-platform Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Kriya Announces Presentations at ASGCT 2026 Highlighting Advances Across Gene Therapy Platform https://ml.globenewswire.com/media/499a8479-725f-44cf-b768-37a114f16b5e/small/kriya-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909341010-pliant-therapeutics-announces-first-patient-dosed-in-fortify-the-phase-1b-indication-expansion-trial-evaluating-pln-101095-in-patients-with Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors https://ml.globenewswire.com/media/6a9e3f3f-d4fb-4bf0-9480-3bbd3fd2ced9/small/pliant-logo-300x300-jpg.jpg https://www.healthbulletinhaiti.com/article/909341014-enlivex-treasury-portfolio-update-listing-of-the-rain-token-on-htx-a-leading-cryptocurrency-exchange Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.healthbulletinhaiti.com/article/909341017-oncotelic-therapeutics-advances-toward-commercial-launch-of-ai-enabled-robotics-platform-following-integration-of-28-million-scientific-abstracts Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Oncotelic Therapeutics Advances Toward Commercial Launch of AI-Enabled Robotics Platform Following Integration of 28 Million Scientific Abstracts https://ml.globenewswire.com/media/aa650511-a1c3-496e-803a-448d7f8d409a/small/picture1-jpg.jpg https://www.healthbulletinhaiti.com/article/909341040-spectral-ai-wins-small-business-innovator-award-at-inaugural-texas-innovation-conference Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Spectral AI Wins Small Business Innovator Award at Inaugural Texas Innovation Conference https://ml.globenewswire.com/media/e51098e6-329d-4efc-acb5-a92a6b8f2a5d/small/spectral-ai-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909341073-quoin-pharmaceuticals-to-announce-corporate-update-and-first-quarter-2026-financial-results-on-thursday-may-7-2026 Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Quoin Pharmaceuticals to Announce Corporate Update and First Quarter 2026 Financial Results on Thursday, May 7, 2026 https://ml.globenewswire.com/media/7002de7e-dd04-45a5-a382-625d5317dbfd/small/quoin-colored-logo-png-png.png https://www.healthbulletinhaiti.com/article/909341096-cadrenal-therapeutics-announces-end-of-phase-2-meeting-with-the-fda-and-pivotal-phase-3-registration-path-for-cad-1005-in-heparin-induced Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Cadrenal Therapeutics Announces End-of-Phase 2 Meeting with the FDA and Pivotal Phase 3 Registration Path for CAD-1005 in Heparin-Induced Thrombocytopenia (HIT) https://ml.globenewswire.com/media/dec0fe5d-b262-4ca7-94e0-1fd3856d07a8/small/cvkd-logo-2025-png.png https://www.healthbulletinhaiti.com/article/909341123-vicarious-surgical-reports-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Vicarious Surgical Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/YWM2NTM0NGItOThhNS00OTcxLTg0NjctZjY2MTlkZjMwMTZkLTEyMTM5OTQtMjAyNi0wNC0zMC1lbg==/tiny/Vicarious-Surgical.png https://www.healthbulletinhaiti.com/article/909341127-microbot-medical-announces-the-addition-of-senior-commercial-executive-with-proven-track-record-to-accelerate-commercial-readiness-in-europe-the Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA) https://ml.globenewswire.com/media/346df7fb-c134-40c2-970a-39bcbaf974cd/small/mbot-logo-rgb-jpg.jpg https://www.healthbulletinhaiti.com/article/909341169-fibrobiologics-announces-poster-presentation-at-the-society-for-investigative-dermatology-annual-meeting-2026 Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 FibroBiologics Announces Poster Presentation at the Society for Investigative Dermatology Annual Meeting 2026 https://ml.globenewswire.com/media/720fe0fe-52b4-4ccc-a5ad-95d4288f1df2/small/fibrobiologics-logo-2022-jpg.jpg https://www.healthbulletinhaiti.com/article/909341193-opko-health-expands-nicoya-agreement-to-support-rayaldee-commercialization-in-greater-china Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 OPKO Health Expands Nicoya Agreement to Support RAYALDEE® Commercialization in Greater China https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.healthbulletinhaiti.com/article/909341279-tomi-environmental-solutions-signs-letter-of-intent-for-a-merger-with-carbonium-core-inc-a-u-s-based-producer-of-nuclear-grade-graphite-for Health Bulletin Haiti en PressRelease 2026-04-30T12:30:00+00:00 TOMI Environmental Solutions Signs Letter of Intent for a Merger with Carbonium Core, Inc., a U.S.-Based Producer of Nuclear-Grade Graphite for Advanced Reactors and Infrastructure Demands of AI Data Centers https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthbulletinhaiti.com/article/909336755-newcelx-reports-financial-results-for-2025-and-provides-shareholders-with-update-on-accelerated-development-of-type-1-diabetes-treatment-in Health Bulletin Haiti en PressRelease 2026-04-30T12:15:00+00:00 NewcelX Reports Financial Results for 2025 and Provides Shareholders with Update on Accelerated Development of Type 1 Diabetes Treatment in Collaboration with Eledon Pharmaceuticals in 2026 https://ml.globenewswire.com/media/ac801d4e-6ea5-4452-87c2-aa6a05bec73c/small/logo-positive-2x-jpg.jpg https://www.healthbulletinhaiti.com/article/909336237-sangamo-therapeutics-to-present-pipeline-and-technology-advances-at-the-29th-annual-meeting-of-the-american-society-of-gene-cell-therapy-asgct Health Bulletin Haiti en PressRelease 2026-04-30T12:05:00+00:00 Sangamo Therapeutics to Present Pipeline and Technology Advances at the 29th Annual Meeting of The American Society of Gene & Cell Therapy (ASGCT) https://ml.globenewswire.com/media/e3084490-aff3-4c15-8036-d94123563fd0/small/sangamo-logotm-11-11zon-png.png https://www.healthbulletinhaiti.com/article/909336200-pelvic-rehabilitation-medicine-expands-san-antonio-center-with-new-endometriosis-specialists Health Bulletin Haiti en PressRelease 2026-04-30T12:04:00+00:00 Pelvic Rehabilitation Medicine Expands San Antonio Center with New Endometriosis Specialists https://ml.globenewswire.com/media/Y2I0ZGE4MGYtM2NmMi00OTNkLWEyYmYtNTg0NTljMmU5MWFiLTUwMDEyNjg3Ni0yMDI2LTA0LTMwLWVu/tiny/Pelvic-Rehabilitation-Medicine.png https://www.healthbulletinhaiti.com/article/909336831-inspira-and-qarakal-sign-joint-development-agreement-for-cryogenic-interconnects-in-superconducting-quantum-systems Health Bulletin Haiti en PressRelease 2026-04-30T12:01:00+00:00 Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems https://ml.globenewswire.com/media/6a4eabfe-c9ec-40d1-87fc-6f0d8e6e408c/small/screenshot-2025-04-02-at-19-21-06-png.png https://www.healthbulletinhaiti.com/article/909336129-electrocore-tac-stim-named-national-semifinalist-in-national-safety-council-work-to-zero-challenge Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 electroCore TAC-STIM™ Named National Semifinalist in National Safety Council Work to Zero Challenge https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.healthbulletinhaiti.com/article/909336141-elicio-therapeutics-to-present-at-the-bank-of-america-healthcare-conference Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Elicio Therapeutics to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/d588dddd-266e-4f3e-930a-d4c5ba15fe31/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909336149-proqr-announces-nomination-of-dr-lykke-hinsch-gylvin-to-its-board-of-directors Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors https://ml-eu.globenewswire.com/media/f5ae7794-bff7-44dc-8709-0e9c3a9eac77/small/logo-proqr-150x150-png.png https://www.healthbulletinhaiti.com/article/909336153-cytomx-therapeutics-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/c252869d-a4c1-4e56-88e8-d80b85d20c35/small/cytomx-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909336184-krystal-biotech-to-present-at-upcoming-scientific-conferences Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Krystal Biotech to Present at Upcoming Scientific Conferences https://ml.globenewswire.com/media/94ec1f39-c0eb-4e65-9d7e-250519ef03f4/small/krys-logo-nobackground-with-registered-symbol-png.png https://www.healthbulletinhaiti.com/article/909336188-inmune-bio-inc-to-report-first-quarter-2026-financial-results-and-provide-corporate-update-on-thursday-may-7th Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.healthbulletinhaiti.com/article/909336192-lexicon-pharmaceuticals-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/afcf3b59-ca71-40ed-9226-a0901bf4d13b/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909336196-picard-medical-syncardia-recognizes-banner-health-as-global-leader-and-supporter-in-the-advancement-of-total-artificial-heart-technology Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart Technology https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.healthbulletinhaiti.com/article/909336298-bioreference-launches-bioreference-direct-expanding-access-to-consumer-initiated-diagnostic-testing-through-a-fully-integrated-digital-platform Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform https://ml.globenewswire.com/media/ed68aecb-6753-42d8-8b52-a6ec3e054b34/small/opko-png.png https://www.healthbulletinhaiti.com/article/909336338-solid-biosciences-to-showcase-a-large-presence-at-the-29th-annual-meeting-of-the-american-society-of-gene-and-cell-therapy Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy https://ml.globenewswire.com/media/bb5e6b30-d9d9-464f-8c64-33a09eacc3fb/small/solid-1029x579-png.png https://www.healthbulletinhaiti.com/article/909336397-alx-oncology-announces-that-cd47-biomarker-data-from-clinical-trial-evaluating-evorpacept-zanidatamab-combination-in-advanced-breast-cancer-will-be Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 ALX Oncology Announces That CD47 Biomarker Data from Clinical Trial Evaluating Evorpacept + Zanidatamab Combination in Advanced Breast Cancer Will Be Presented at ESMO Breast Cancer 2026 https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.healthbulletinhaiti.com/article/909336543-immutep-receives-nasdaq-notice-of-bid-price-deficiency Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Immutep Receives Nasdaq Notice of Bid Price Deficiency https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.healthbulletinhaiti.com/article/909336621-immutep-quarterly-activities-report-q3-fy26 Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 Immutep Quarterly Activities Report Q3 FY26 https://ml.globenewswire.com/media/b2cd55d0-59ab-45ac-a1fe-5cf2adac7f24/small/immutep-new-logo-png.png https://www.healthbulletinhaiti.com/article/909336761-urevo-wins-if-design-award-2026-for-ai-powered-wireless-recovery-boots Health Bulletin Haiti en PressRelease 2026-04-30T12:00:00+00:00 UREVO Wins iF Design Award 2026 for AI-Powered Wireless Recovery Boots https://ml.globenewswire.com/Resource/Download/757dd5d6-9737-4d31-bc73-5ab49b424ccc/urevo-2.jpeg https://www.healthbulletinhaiti.com/article/909331351-emergent-biosolutions-receives-approval-from-singapore-health-sciences-authority-for-expanded-indication-of-acam2000-smallpox-and-mpox-vaccinia Health Bulletin Haiti en PressRelease 2026-04-30T11:55:00+00:00 Emergent BioSolutions Receives Approval from Singapore Health Sciences Authority for Expanded Indication of ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) to Include Mpox https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://www.healthbulletinhaiti.com/article/909326457-aptose-biosciences-announces-update-on-anticipated-timing-of-closing-of-the-plan-of-arrangement-with-hanmi-pharmaceutical Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical https://ml.globenewswire.com/media/3f4ab307-5947-4ef1-b5b5-c2c66933728a/small/aptose-biosciences-inc-logo.jpg https://www.healthbulletinhaiti.com/article/909326459-bridgebio-to-report-first-quarter-2026-financial-results-and-commercial-updates-on-may-7-2026-at-4-30-pm-et Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 BridgeBio to Report First Quarter 2026 Financial Results and Commercial Updates on May 7, 2026 at 4:30 pm ET https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthbulletinhaiti.com/article/909326468-siga-to-host-business-update-call-on-may-7-2026-following-release-of-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results https://ml.globenewswire.com/media/93028aa6-8191-4392-a7b1-447b046cd93b/small/siga-logo-blue-png.png https://www.healthbulletinhaiti.com/article/909326486-barinthus-bio-reports-first-quarter-2026-financial-results-and-updates-on-corporate-developments Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments https://ml.globenewswire.com/media/284aac16-bab8-47d0-8077-929f11b0088b/small/barinthuslogo-jpg.jpg https://www.healthbulletinhaiti.com/article/909326518-palvella-therapeutics-to-host-first-quarter-2026-financial-results-and-corporate-update-conference-call-on-may-7-2026 Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 Palvella Therapeutics to Host First Quarter 2026 Financial Results and Corporate Update Conference Call on May 7, 2026 https://ml.globenewswire.com/media/83fd569b-5e6c-46ad-882a-6430f8ab755a/small/palvella-2025-logo-new-jpg.jpg https://www.healthbulletinhaiti.com/article/909326529-tg-therapeutics-to-host-conference-call-on-first-quarter-2026-financial-results-and-business-update Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 TG Therapeutics to Host Conference Call on First Quarter 2026 Financial Results and Business Update https://ml.globenewswire.com/media/0e613f5f-8c22-4c63-a73b-c08cc0fbec64/small/tgtx-2021-logo.jpg https://www.healthbulletinhaiti.com/article/909326535-helus-pharma-to-participate-at-the-29th-annual-milken-institute-global-conference Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 Helus Pharma to Participate at the 29th Annual Milken Institute Global Conference https://ml.globenewswire.com/media/575a4e81-a546-4d83-a092-e8f0df765900/small/hp-pms-with-margins-png.png https://www.healthbulletinhaiti.com/article/909326559-medicenna-and-fondazione-melanoma-onlus-announce-presentation-on-neocyt-trial-at-asco-2026 Health Bulletin Haiti en PressRelease 2026-04-30T11:30:00+00:00 Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026 https://ml.globenewswire.com/media/7e312e67-9924-4773-b548-47ed05d54904/small/new-logo-small-png.png https://www.healthbulletinhaiti.com/article/909326545-alterity-therapeutics-releases-appendix-4c-q3-fy26-quarterly-cash-flow-report-corporate-update Health Bulletin Haiti en PressRelease 2026-04-30T11:25:00+00:00 Alterity Therapeutics Releases Appendix 4C – Q3 FY26 Quarterly Cash Flow Report & Corporate Update https://ml.globenewswire.com/media/0771a9a2-2ac1-4a63-9767-a2b1df74af27/small/alterity-png.png https://www.healthbulletinhaiti.com/article/909326526-aurora-spine-corporation-announces-record-fourth-quarter-and-fy25-financial-results Health Bulletin Haiti en PressRelease 2026-04-30T11:15:00+00:00 Aurora Spine Corporation Announces Record Fourth Quarter and FY25 Financial Results https://ml.globenewswire.com/media/af1a0a7b-b883-41f9-8c86-a89bad3cc4a4/small/aurora12-jpg.JPG https://www.healthbulletinhaiti.com/article/909321648-ac-immune-first-quarter-2026-financial-and-corporate-updates Health Bulletin Haiti en PressRelease 2026-04-30T11:05:00+00:00 AC Immune First Quarter 2026 Financial and Corporate Updates https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909321659-option-care-health-announces-financial-results-for-the-first-quarter-ended-march-31-2026 Health Bulletin Haiti en PressRelease 2026-04-30T11:05:00+00:00 Option Care Health Announces Financial Results for the First Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/OTMwMzk0MzMtYzkxYi00NzYzLTg4MTYtYzRlNDIyNGM0YzZmLTEwMTk5NzQtMjAyNi0wNC0zMC1lbg==/tiny/Option-Care-Health-Inc-.png https://www.healthbulletinhaiti.com/article/909321723-uniqure-announces-successful-uk-mhra-pre-submission-meeting-for-amt-130-in-huntington-s-disease Health Bulletin Haiti en PressRelease 2026-04-30T11:05:00+00:00 uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease https://ml.globenewswire.com/media/2ba61fe2-12e5-4a01-afe1-419652b31512/small/logo-uniqure-ms-word-orange-jpg.jpg https://www.healthbulletinhaiti.com/article/909321633-indivior-reports-first-quarter-2026-financial-results-and-raises-full-year-2026-guidance Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Indivior Reports First Quarter 2026 Financial Results and Raises Full-Year 2026 Guidance https://ml-eu.globenewswire.com/media/42de3285-90ea-4020-a3ad-25f71026b41a/small/indivior-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909321646-novartis-finalizes-us-manufacturing-and-r-d-expansion-plan-with-seventh-new-facility Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Novartis finalizes US manufacturing and R&D expansion plan with seventh new facility https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://www.healthbulletinhaiti.com/article/909321647-ac-immune-initiates-final-cohort-in-ongoing-phase-1b-2-abate-trial-of-anti-abeta-active-immunotherapy-to-treat-alzheimer-s-disease Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease https://ml-eu.globenewswire.com/media/0065cdfd-b9fc-4994-8aca-731c1d031b51/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909321682-axogen-inc-to-participate-in-the-2026-bank-of-america-global-healthcare-conference Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference https://ml.globenewswire.com/media/3e4ffe78-2e9a-4972-915e-28c8477c84c1/small/axogen-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909321691-kymera-therapeutics-announces-first-quarter-2026-financial-results-and-provides-a-business-update Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Kymera Therapeutics Announces First Quarter 2026 Financial Results and Provides a Business Update https://ml.globenewswire.com/media/4d3d3283-c57d-401e-9e1b-53f17e22d76b/small/kymera-logo-rgb-denim-marigold-high-res-png.png https://www.healthbulletinhaiti.com/article/909321729-lensar-to-report-first-quarter-2026-results-on-may-8-2026 Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 LENSAR® to Report First Quarter 2026 Results on May 8, 2026 https://ml.globenewswire.com/media/4768eddf-0f87-4479-87f6-6b81f8ff392a/small/lensar-4color-jpg.jpg https://www.healthbulletinhaiti.com/article/909321738-the-power-of-community-to-improve-asthma-and-allergy-health Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 The Power of Community to Improve Asthma and Allergy Health https://ml.globenewswire.com/media/YWIzMzVhYzUtOWVhOC00NzhmLWE2ODItNjhhZTk1ZjZiYjcwLTExMDE5NjItMjAyNi0wNC0zMC1lbg==/tiny/Asthma-and-Allergy-Foundation-.png https://www.healthbulletinhaiti.com/article/909321739-cartesian-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/2bf78841-be30-4bb5-bfb5-0b5f383f3302/small/cartesian-logo-color-png.png https://www.healthbulletinhaiti.com/article/909321764-sweetwater-brewing-company-and-salt-life-launch-livin-salty-the-ultimate-summer-craft-brew-collaboration Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 SweetWater Brewing Company and Salt Life Launch Livin’ Salty: The Ultimate Summer Craft Brew Collaboration https://ml.globenewswire.com/media/44db68a9-d316-445f-aa24-0359e453f966/medium/livin-salty.jpeg https://www.healthbulletinhaiti.com/article/909321805-netramark-to-open-the-market-at-the-toronto-stock-exchange-on-may-5-2026 Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 NetraMark To Open The Market At The Toronto Stock Exchange On May 5, 2026 https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.healthbulletinhaiti.com/article/909321903-biostem-strengthens-leadership-team-with-appointment-of-katherine-gorrell-as-chief-legal-compliance-officer Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 BioStem Strengthens Leadership Team with Appointment of Katherine Gorrell as Chief Legal & Compliance Officer https://ml.globenewswire.com/media/da0ea21a-fd6e-425a-a8f2-6f69dc2b4612/small/biostem-main-logo-png.png https://www.healthbulletinhaiti.com/article/909321995-royal-columbian-hospital-begins-patient-recruitment-in-arch-biopartners-phase-ii-trial-of-lsalt-peptide-targeting-cs-aki Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Royal Columbian Hospital begins patient recruitment in Arch Biopartners’ Phase II trial of LSALT peptide targeting CS-AKI https://ml.globenewswire.com/media/8fae7e83-0899-4bbc-ba40-0250cdb9aea7/small/logo-png.png https://www.healthbulletinhaiti.com/article/909322040-verano-announces-strong-first-quarter-2026-financial-results-highlighted-by-208-million-in-revenue Health Bulletin Haiti en PressRelease 2026-04-30T11:00:00+00:00 Verano Announces Strong First Quarter 2026 Financial Results Highlighted by $208 Million in Revenue https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://www.healthbulletinhaiti.com/article/909321761-phathom-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Health Bulletin Haiti en PressRelease 2026-04-30T10:59:00+00:00 Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/0baa6f51-c6cb-4b21-a4e0-573a18b8171c/small/phathom-pharm-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909317221-verano-announces-20-million-share-repurchase-authorization Health Bulletin Haiti en PressRelease 2026-04-30T10:35:00+00:00 Verano Announces $20 Million Share Repurchase Authorization https://ml.globenewswire.com/media/18f2c9e0-d960-440b-a51f-b7d7ea7c9e08/small/verano-company-logo-png.png https://www.healthbulletinhaiti.com/article/909308015-greenwich-lifesciences-provides-update-regarding-form-10-k-filing Health Bulletin Haiti en PressRelease 2026-04-30T10:00:00+00:00 Greenwich LifeSciences Provides Update Regarding Form 10-K Filing https://ml.globenewswire.com/media/e0bfd967-b05f-43d2-91b4-d2a5d551df99/small/logo-edited-jpg.jpg https://www.healthbulletinhaiti.com/article/909308065-northwestern-medicine-opens-15-million-center-expanding-advanced-gastrointestinal-care-to-suburban-chicago Health Bulletin Haiti en PressRelease 2026-04-30T10:00:00+00:00 Northwestern Medicine Opens $15 Million Center Expanding Advanced Gastrointestinal Care to Suburban Chicago https://ml.globenewswire.com/media/c818b3e2-cc21-412d-adb9-1907c8973777/medium/center-for-advanced-endoscopy-physician-team.jpg https://www.healthbulletinhaiti.com/article/909308123-aclarion-delivers-strong-q1-2026-results-with-196-annual-scan-volume-growth-reflecting-accelerating-clinical-adoption Health Bulletin Haiti en PressRelease 2026-04-30T10:00:00+00:00 Aclarion Delivers Strong Q1 2026 Results with 196% Annual Scan Volume Growth Reflecting Accelerating Clinical Adoption https://ml.globenewswire.com/media/6650177f-80b7-4c94-afb4-fc63aa3ada98/small/logo-png.png https://www.healthbulletinhaiti.com/article/909299246-genembryomics-and-genomic-prediction-launch-xgen-pgt-x Health Bulletin Haiti en PressRelease 2026-04-30T09:07:33+00:00 GenEmbryomics and Genomic Prediction Launch XGEN PGT-X™ https://ml.globenewswire.com/media/35292517-cd2b-4358-af63-93771c4db2f3/small/picture1-jpg.jpg https://www.healthbulletinhaiti.com/article/909272955-orchard-therapeutics-awarded-innovation-passport-designation-for-otl-201-in-mps-iiia Health Bulletin Haiti en PressRelease 2026-04-30T06:30:00+00:00 Orchard Therapeutics Awarded Innovation Passport Designation for OTL-201 in MPS-IIIA https://ml.globenewswire.com/media/00f8bc36-9b68-4343-b7fe-1325d14b6393/small/orchard-kkc-logo-rgb-png.png https://www.healthbulletinhaiti.com/article/909258262-nicox-provides-full-year-2025-financial-results-and-corporate-update Health Bulletin Haiti en PressRelease 2026-04-30T05:30:00+00:00 Nicox Provides Full Year 2025 Financial Results and Corporate Update https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/logo-png.png https://www.healthbulletinhaiti.com/article/909258284-nicox-annonce-ses-r-sultats-financiers-2025-et-fait-un-point-sur-son-activit Health Bulletin Haiti en PressRelease 2026-04-30T05:30:00+00:00 Nicox annonce ses résultats financiers 2025 et fait un point sur son activité https://ml-eu.globenewswire.com/media/c4c68e53-e467-4048-b580-d1596c4d6d8e/small/ https://www.healthbulletinhaiti.com/article/909258286-valneva-annonce-le-succ-s-d-une-offre-r-serv-e-d-un-montant-de-84-millions-d-euros Health Bulletin Haiti en PressRelease 2026-04-30T05:15:00+00:00 Valneva annonce le succès d’une Offre Réservée d’un montant de 84 millions d’euros https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/ https://www.healthbulletinhaiti.com/article/909258295-valneva-announces-the-successful-completion-of-an-84-million-reserved-offering Health Bulletin Haiti en PressRelease 2026-04-30T05:15:00+00:00 Valneva Announces the Successful Completion of an €84 million Reserved Offering https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg https://www.healthbulletinhaiti.com/article/909252187-santhera-schl-gt-dr-srishti-gupta-als-neues-mitglied-des-verwaltungsrats Health Bulletin Haiti en PressRelease 2026-04-30T05:00:00+00:00 Santhera schlägt Dr. Srishti Gupta als neues Mitglied des Verwaltungsrats https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/ https://www.healthbulletinhaiti.com/article/909252198-santhera-proposes-dr-srishti-gupta-as-new-member-of-the-board-of-directors Health Bulletin Haiti en PressRelease 2026-04-30T05:00:00+00:00 Santhera Proposes Dr. Srishti Gupta as New Member of the Board of Directors https://ml-eu.globenewswire.com/media/63cd960e-70ce-4ba8-8984-92f72954c235/small/logo-jpg.JPG https://www.healthbulletinhaiti.com/article/909252203-addex-reports-full-year-2025-financial-results-and-provides-corporate-update Health Bulletin Haiti en PressRelease 2026-04-30T05:00:00+00:00 Addex Reports Full Year 2025 Financial Results and Provides Corporate Update https://ml-eu.globenewswire.com/media/e6c12443-4244-46f9-909c-5ab241bbea41/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909252228-argenx-to-report-first-quarter-2026-financial-results-and-business-update-on-may-7-2026 Health Bulletin Haiti en PressRelease 2026-04-30T05:00:00+00:00 argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://www.healthbulletinhaiti.com/article/909205508-avalyn-announces-pricing-of-upsized-initial-public-offering Health Bulletin Haiti en PressRelease 2026-04-30T01:00:53+00:00 Avalyn Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/84d7bff4-ce17-433b-8c71-aa20c30f9f43/small/avalyn-logo-final-png.png https://www.healthbulletinhaiti.com/article/909197138-mesoblast-reports-ryoncil-net-revenues-of-us-30-3m-and-improved-net-operating-cash-spend-for-the-quarter-to-us-4-1-million Health Bulletin Haiti en PressRelease 2026-04-30T00:55:01+00:00 Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million https://ml.globenewswire.com/media/a9938a8a-a0ba-4708-abd5-2219515343fc/small/mesologo-png.png https://www.healthbulletinhaiti.com/article/909187732-vaccinex-reports-2025-annual-financial-results Health Bulletin Haiti en PressRelease 2026-04-30T00:05:00+00:00 Vaccinex Reports 2025 Annual Financial Results https://ml.globenewswire.com/media/6a5e4bae-ba84-4fb3-a2ad-2cf268bfe3ba/small/vaccinex-logo.jpg https://www.healthbulletinhaiti.com/article/909178327-logicmark-inc-to-announce-first-quarter-2026-financial-results-on-may-13-2026 Health Bulletin Haiti en PressRelease 2026-04-29T23:00:00+00:00 LogicMark, Inc. to Announce First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/a0f92be7-890f-496e-8c58-fc6621df90b0/small/logicmark-primary-color-png.png https://www.healthbulletinhaiti.com/article/909141493-optimal-psma-trial-of-tlx597-tx-next-generation-rlt-presented-at-ipcs-2026-highlighting-therapeutic-potential-in-prostate-cancer Health Bulletin Haiti en PressRelease 2026-04-29T21:00:00+00:00 OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer https://ml.globenewswire.com/media/77ceffdf-31cc-415f-9747-efee950af329/small/telix-main-logo-3-png.png https://www.healthbulletinhaiti.com/article/909141641-neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4 Health Bulletin Haiti en PressRelease 2026-04-29T20:30:00+00:00 Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/12db9039-d4bf-41a0-8b4a-324398e392b4/small/neuronetics-logo-rgb-purple-png.png https://www.healthbulletinhaiti.com/article/909141780-tarsus-to-report-first-quarter-2026-financial-results-on-wednesday-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:30:00+00:00 Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.healthbulletinhaiti.com/article/909131872-crescent-biopharma-reports-first-quarter-2026-financial-results-and-recent-business-highlights Health Bulletin Haiti en PressRelease 2026-04-29T20:15:00+00:00 Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/57dabf2a-90a3-4786-9c39-d1e71cc7707f/small/crescent-biopharma-logo-color-png.png https://www.healthbulletinhaiti.com/article/909133158-serotonin-centers-opens-second-north-texas-location-in-fort-worth-expanding-physician-led-longevity-care Health Bulletin Haiti en PressRelease 2026-04-29T20:11:44+00:00 Serotonin Centers Opens Second North Texas Location in Fort Worth, Expanding Physician-Led Longevity Care https://ml.globenewswire.com/media/3ba07a05-1c88-4e05-bced-ca5d94e0462c/medium/serotonin-centers-fort-worth-team-at-new-location-opening.png https://www.healthbulletinhaiti.com/article/909131707-lifestance-to-present-at-upcoming-investor-conferences Health Bulletin Haiti en PressRelease 2026-04-29T20:10:00+00:00 LifeStance to Present at Upcoming Investor Conferences https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.healthbulletinhaiti.com/article/909131962-rxsight-inc-to-present-at-the-bank-of-america-healthcare-conference Health Bulletin Haiti en PressRelease 2026-04-29T20:10:00+00:00 RxSight, Inc. to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/48441335-c938-45ff-9355-ba8e331354e9/small/rxsight-globe-png.png https://www.healthbulletinhaiti.com/article/909131015-lifecore-biomedical-to-report-financial-results-for-the-first-quarter-ended-march-31-2026-on-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026 https://ml.globenewswire.com/media/ca940278-cc18-4a3f-93b7-d8a034c998c9/small/lifecore-corporate-logo-2c-png.png https://www.healthbulletinhaiti.com/article/909131035-revolution-medicines-to-report-financial-results-for-first-quarter-2026-after-market-close-on-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Revolution Medicines to Report Financial Results for First Quarter 2026 After Market Close on May 6, 2026 https://ml.globenewswire.com/media/771b34d9-586d-435a-a976-ab0ab847571b/small/balanced-green-primary-logo-medium-1000px-png.png https://www.healthbulletinhaiti.com/article/909131048-bionano-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-webcast-on-may-13-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 https://ml.globenewswire.com/media/5ba4072e-6e59-46e7-847c-6aaf7755bbbf/small/bionano-rgb-png.png https://www.healthbulletinhaiti.com/article/909131141-invo-fertility-receives-nasdaq-notification-regarding-late-filing-of-annual-report-on-form-10-k Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K https://ml.globenewswire.com/media/c9819c81-8df5-472e-892b-610465571f75/small/invofertility-jpg.jpg https://www.healthbulletinhaiti.com/article/909131147-dyadic-to-report-q1-2026-financial-results-and-host-conference-call-on-wednesday-may-13-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 https://ml.globenewswire.com/media/c67f7901-660b-41c0-a160-0f92fd04bb42/small/dyadic-applied-biosolutions-jpg.jpg https://www.healthbulletinhaiti.com/article/909131331-ceribell-to-participate-in-the-bank-of-america-securities-2026-health-care-conference Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Ceribell to Participate in the Bank of America Securities 2026 Health Care Conference https://ml.globenewswire.com/media/937c5c00-41f8-45ff-b294-5f9c3f6ab2cf/small/cbll-square-logo-500x500-png.png https://www.healthbulletinhaiti.com/article/909131510-sight-sciences-to-present-at-two-upcoming-investor-conferences Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Sight Sciences to Present at Two Upcoming Investor Conferences https://ml.globenewswire.com/media/e7536623-9fa4-42d0-896d-04ddb984ef4e/small/sght-logo-png.png https://www.healthbulletinhaiti.com/article/909131575-mineralys-therapeutics-to-announce-first-quarter-2026-financial-results-and-host-conference-call-on-wednesday-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Mineralys Therapeutics to Announce First Quarter 2026 Financial Results and Host Conference Call on Wednesday, May 6, 2026 https://ml.globenewswire.com/media/2f3e6873-8e64-406e-832e-7df0f6d79a56/small/mineralys-therapeutics-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909132068-avita-medical-announces-tga-certification-in-australia-and-medsafe-wand-listing-in-new-zealand-for-recell-go Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO https://ml.globenewswire.com/media/53ad8139-952a-4470-9ede-2f3bf0521f16/small/avita-png.png https://www.healthbulletinhaiti.com/article/909132098-seer-to-report-first-quarter-2026-financial-results-on-may-13-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Seer to Report First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/a5aaadad-13a1-4dbd-8ba2-d57cbbc610fb/small/seer-brandmark-rgb-full-jpg.jpg https://www.healthbulletinhaiti.com/article/909132115-maxcyte-to-report-first-quarter-2026-financial-results-on-may-12-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 MaxCyte to Report First Quarter 2026 Financial Results on May 12, 2026 https://ml.globenewswire.com/media/8f0f0d48-fc4f-4d03-ac70-f4d096a780bd/small/maxcyte-logo-600x600-png.png https://www.healthbulletinhaiti.com/article/909132131-teladoc-health-reports-first-quarter-2026-results Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Teladoc Health Reports First Quarter 2026 Results https://ml.globenewswire.com/media/439ced23-c1ca-477b-8607-8067a1777d11/small/tdh-logo-png.png https://www.healthbulletinhaiti.com/article/909132256-relay-therapeutics-to-announce-first-quarter-2026-financial-results-and-corporate-highlights-on-may-5-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:05:00+00:00 Relay Therapeutics to Announce First Quarter 2026 Financial Results and Corporate Highlights on May 5, 2026 https://ml.globenewswire.com/media/079b6db5-ce81-4a81-9cde-d97f86c569ae/small/logo-banner-small-png.png https://www.healthbulletinhaiti.com/article/909132002-procept-biorobotics-reports-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-04-29T20:03:00+00:00 PROCEPT BioRobotics Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/fc9b1b79-13a0-4245-a974-081e3ceaafcb/small/procept-logo-png.PNG https://www.healthbulletinhaiti.com/article/909131088-mannkind-to-report-first-quarter-2026-financial-results-on-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T20:01:00+00:00 MannKind to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/fc4da88e-772c-44f1-87a9-36ece175bc5b/small/mannkind-logo-rgb-1200x628-png.png https://www.healthbulletinhaiti.com/article/909131236-olema-oncology-appoints-prakash-raman-ph-d-to-board-of-directors Health Bulletin Haiti en PressRelease 2026-04-29T20:01:00+00:00 Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors https://ml.globenewswire.com/media/9c736753-c905-4bd1-ac3a-1444bea84331/small/olema-logo-rgb-png.png https://www.healthbulletinhaiti.com/article/909132033-mimedx-announces-first-quarter-2026-operating-financial-results Health Bulletin Haiti en PressRelease 2026-04-29T20:01:00+00:00 MIMEDX Announces First Quarter 2026 Operating & Financial Results https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.healthbulletinhaiti.com/article/909131040-parexel-adds-new-technology-capabilities-in-patient-safety-solutions-with-acquisition-of-vitrana Health Bulletin Haiti en PressRelease 2026-04-29T20:00:00+00:00 Parexel Adds New Technology Capabilities in Patient Safety Solutions with Acquisition of Vitrana https://ml.globenewswire.com/media/9fb4b992-112d-493e-8212-d357da896d03/small/parexel-master-logo-cmyk-png.png https://www.healthbulletinhaiti.com/article/909099738-royal-columbian-hospital-foundation-unveils-the-jack-sylvia-gin-emergency-trauma-imaging-centre-ginetic Health Bulletin Haiti en PressRelease 2026-04-29T17:44:59+00:00 Royal Columbian Hospital Foundation unveils the Jack & Sylvia Gin Emergency & Trauma Imaging Centre (GinETIC) https://ml.globenewswire.com/media/4303b18b-2944-4c27-8cf2-727d5420a76a/medium/jack-and-sylvia-gin-ribbon-cutting-ceremony.jpg https://www.healthbulletinhaiti.com/article/909089614-sapho-bio-secures-5m-advances-rapid-sterility-testing-through-usp-1223-validation Health Bulletin Haiti en PressRelease 2026-04-29T17:38:37+00:00 Sapho Bio Secures $5M, Advances Rapid Sterility Testing Through USP<1223> Validation https://ml.globenewswire.com/media/MTgzZWY1OWYtZmY2OC00OWE1LThlODYtMWJlMzNiY2ZiNjUyLTEzMjMwNDYtMjAyNi0wNC0yOS1lbg==/tiny/Sapho-Bio.png https://www.healthbulletinhaiti.com/article/909080187-zealand-pharma-and-roche-to-advance-petrelintide-an-amylin-analog-to-phase-3-trials-for-chronic-weight-management Health Bulletin Haiti en PressRelease 2026-04-29T17:01:00+00:00 Zealand Pharma and Roche to advance petrelintide, an amylin analog, to Phase 3 trials for chronic weight management https://ml-eu.globenewswire.com/media/31b5d115-c4a3-4dfd-b20e-d222199c4862/small/zealand-logo-1-png.png https://www.healthbulletinhaiti.com/article/909080348-centurion-service-group-and-auction-advisors-announce-major-auction-of-assets-from-fromer-eye-centers Health Bulletin Haiti en PressRelease 2026-04-29T17:00:00+00:00 Centurion Service Group and Auction Advisors announce major auction of assets from Fromer Eye Centers https://ml.globenewswire.com/media/MGRlMjg3NmQtMTJmYy00NTg0LTljYTUtYWFkYTFlYjcyZjg0LTEyNjg3NzMtMjAyNi0wNC0yOS1lbg==/tiny/Centurion-Service-Group-A-TRIM.png https://www.healthbulletinhaiti.com/article/909080505-pr-parez-vous-bouger-pour-la-sant-mentale-des-femmes-la-course-pour-les-femmes-de-pharmaprix-md-est-de-retour Health Bulletin Haiti en PressRelease 2026-04-29T17:00:00+00:00 Préparez-vous à bouger pour la santé mentale des femmes : La Course pour les femmes de Pharmaprix(MD) est de retour https://ml.globenewswire.com/media/YjM1ZjNiN2YtYjA1ZS00M2M0LTljM2EtNWI3MTA3NjA3NjY1LTEyMDc5OTYtMjAyNi0wNC0yOS1mcg==/tiny/Loblaws-Inc-.png https://www.healthbulletinhaiti.com/article/909080517-get-ready-to-move-for-women-s-mental-health-the-2026-shoppers-drug-mart-run-for-women-returns Health Bulletin Haiti en PressRelease 2026-04-29T17:00:00+00:00 Get Ready to Move for Women’s Mental Health: The 2026 Shoppers Drug Mart® Run for Women Returns https://ml.globenewswire.com/media/Y2MzMTY4YjctZTBlYy00M2Y2LTk1YTUtMjU0NzMzYTMzMGU5LTEyMDc5OTYtMjAyNi0wNC0yOS1lbg==/tiny/Loblaws-Inc-.png https://www.healthbulletinhaiti.com/article/909080677-ehs-opens-walsh-ambulatory-pavilion-expanding-access-to-advanced-outpatient-care Health Bulletin Haiti en PressRelease 2026-04-29T16:54:07+00:00 EHS Opens Walsh Ambulatory Pavilion, Expanding Access to Advanced Outpatient Care https://ml.globenewswire.com/media/e30a5f00-62f8-49b4-af08-483af69f9446/medium/episcopal-health-services-executive-leadership.jpg https://www.healthbulletinhaiti.com/article/909071847-fda-releases-results-from-largest-ever-testing-of-infant-formula-in-the-u-s Health Bulletin Haiti en PressRelease 2026-04-29T16:19:09+00:00 FDA Releases Results from Largest-Ever Testing of Infant Formula in the U.S. https://ml.globenewswire.com/media/ODEwY2UzM2ItNDQyMS00OWVlLWE1NmEtM2VkNTU2NjEwZjZjLTUwMDE1NDE1NC0yMDI2LTA0LTI5LWVu/tiny/FDA.png https://www.healthbulletinhaiti.com/article/909070287-press-release-annual-general-meeting-of-april-29-2026-bel-n-garijo-appointed-as-director-and-chief-executive-officer-of-sanofi Health Bulletin Haiti en PressRelease 2026-04-29T16:00:10+00:00 Press Release: Annual General Meeting of April 29, 2026 - Belén Garijo appointed as Director and Chief Executive Officer of Sanofi https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909070395-communiqu-de-presse-assembl-e-g-n-rale-annuelle-du-29-avril-2026-bel-n-garijo-nomm-e-administratrice-et-directrice-g-n-rale-de-sanofi Health Bulletin Haiti en PressRelease 2026-04-29T16:00:10+00:00 Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - Belén Garijo nommée administratrice et Directrice générale de Sanofi https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909070061-carbios-files-its-2025-universal-registration-document Health Bulletin Haiti en PressRelease 2026-04-29T16:00:00+00:00 Carbios files its 2025 Universal Registration Document https://ml-eu.globenewswire.com/media/8e231c52-09f3-4f09-8a44-39b6065d2245/small/logo-carbios-stacked-rgb-png.png https://www.healthbulletinhaiti.com/article/909070175-carbios-annonce-la-mise-disposition-de-son-document-d-enregistrement-universel-2025 Health Bulletin Haiti en PressRelease 2026-04-29T16:00:00+00:00 CARBIOS annonce la mise à disposition de son Document d’enregistrement universel 2025 https://ml-eu.globenewswire.com/media/8e231c52-09f3-4f09-8a44-39b6065d2245/small/ https://www.healthbulletinhaiti.com/article/909071094-nadp-advocates-greater-access-to-care-through-dental-coverage Health Bulletin Haiti en PressRelease 2026-04-29T16:00:00+00:00 NADP advocates greater access to care through dental coverage https://ml.globenewswire.com/media/4a10cf41-2ae9-4a40-a33e-49e2ed33e40f/small/nadp-logo-horizontal-2024-final-jpg.jpg https://www.healthbulletinhaiti.com/article/909052116-u-s-news-world-report-announces-best-of-2026-ratings-for-legend-senior-living-residences Health Bulletin Haiti en PressRelease 2026-04-29T15:00:00+00:00 U.S. News & World Report Announces "Best of" 2026 Ratings for Legend Senior Living® Residences https://ml.globenewswire.com/media/6ac38cb9-2e04-40fe-82c1-63dbc634b3b0/small/legend-senior-living-logo-2c-pantone-coated-jpg.jpg https://www.healthbulletinhaiti.com/article/909052122-the-american-case-management-association-and-xsolis-announce-2026-case-management-hero-award-honorees Health Bulletin Haiti en PressRelease 2026-04-29T14:54:17+00:00 The American Case Management Association and Xsolis Announce 2026 Case Management Hero Award Honorees https://ml.globenewswire.com/media/MWQ0YjYzMzktZmQ2Yi00ODE4LWE5ODItMWU3Y2MzNzcxOGNiLTUwMDEyNzI3My0yMDI2LTA0LTI5LWVu/tiny/American-Case-Management-Assoc.png https://www.healthbulletinhaiti.com/article/909051602-global-wound-care-market-to-reach-usd-30-48-billion-by-2030-marketsandmarkets Health Bulletin Haiti en PressRelease 2026-04-29T14:30:00+00:00 Global Wound Care Market to Reach USD 30.48 Billion by 2030 | MarketsandMarkets™ https://ml.globenewswire.com/media/afcc5182-4ae0-43a8-a965-4351d590b7ed/small/mnm-logo-tm-jpg-jpg.JPG https://www.healthbulletinhaiti.com/article/909051958-stopping-the-silent-killer-how-to-check-prevent-and-manage-high-blood-pressure Health Bulletin Haiti en PressRelease 2026-04-29T14:25:38+00:00 Stopping the ‘Silent Killer:’ How to Check, Prevent and Manage High Blood Pressure https://ml.globenewswire.com/Resource/Download/394fa13f-a70f-4d09-8dd5-28c52d78d052/17852-1.jpg https://www.healthbulletinhaiti.com/article/909043253-syncromune-inc-presents-innovative-sync-t-combination-immunotherapy-approach-at-major-european-interventional-oncology-conference Health Bulletin Haiti en PressRelease 2026-04-29T14:06:20+00:00 Syncromune®, Inc. Presents Innovative SYNC-T™ Combination Immunotherapy Approach at Major European Interventional Oncology Conference https://ml.globenewswire.com/media/514a0fab-cb37-4a81-bff6-bc951a2b464a/small/syncronome-jpg.jpg https://www.healthbulletinhaiti.com/article/909043114-skinhealth-systems-to-report-first-quarter-2026-financial-results-on-may-7-2026 Health Bulletin Haiti en PressRelease 2026-04-29T14:00:00+00:00 SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026 https://ml.globenewswire.com/media/187132d2-7aef-4a14-8cd2-07829cc11496/small/skinhealthsystems-logo-black-jpg.jpg https://www.healthbulletinhaiti.com/article/909043187-cristcot-to-present-oral-abstract-at-2026-digestive-disease-week-ddw Health Bulletin Haiti en PressRelease 2026-04-29T14:00:00+00:00 Cristcot to Present Oral Abstract at 2026 Digestive Disease Week (DDW) https://ml.globenewswire.com/media/YWVmMWU2MzEtY2YwYy00ZmUzLTg3MjctY2E4YWI4MDQ4MjkwLTEzMjI0MTAtMjAyNi0wNC0yOS1lbg==/tiny/Cristcot-LLC.png https://www.healthbulletinhaiti.com/article/909035246-silo-pharma-s-ptsd-program-advances-as-fda-fast-tracks-psychedelic-therapies-for-ptsd Health Bulletin Haiti en PressRelease 2026-04-29T13:08:00+00:00 Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png https://www.healthbulletinhaiti.com/article/909035178-adial-pharmaceuticals-advances-ip-portfolio-with-new-u-s-utility-patent-application-positioning-for-potential-market-exclusivity-through-2045 Health Bulletin Haiti en PressRelease 2026-04-29T13:07:00+00:00 Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045 https://ml.globenewswire.com/media/e6fc09f7-5847-46c8-9294-f51162a7e518/small/adil-logo-png.png https://www.healthbulletinhaiti.com/article/909035516-dr-carsten-engel-joins-joint-commission-as-international-strategic-advisor Health Bulletin Haiti en PressRelease 2026-04-29T13:00:16+00:00 Dr. Carsten Engel Joins Joint Commission as International Strategic Advisor https://ml.globenewswire.com/media/MzExYzE4NjQtOTU0ZS00YzllLWE2YzctZTAwZjY5MTU0OGQ0LTUwMDE1ODA0Ny0yMDI2LTA0LTI5LWVu/tiny/Joint-Commission.png https://www.healthbulletinhaiti.com/article/909035291-doheny-eye-institute-researchers-to-share-cutting-edge-vision-science-across-more-than-20-sessions-at-the-association-for-research-in-vision-and Health Bulletin Haiti en PressRelease 2026-04-29T13:00:00+00:00 Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting https://ml.globenewswire.com/media/d5e10c15-643a-41f3-9314-a475de3f3d0d/small/doheny-uclastein-pms-png.png https://www.healthbulletinhaiti.com/article/909035311-codexis-to-share-rna-manufacturing-advances-at-tides-usa Health Bulletin Haiti en PressRelease 2026-04-29T13:00:00+00:00 Codexis to share RNA manufacturing advances at TIDES USA https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://www.healthbulletinhaiti.com/article/909035502-xtl-biopharmaceuticals-to-acquire-psyga-bio-establishing-a-leading-psychedelic-biotechnology-platform-with-advanced-clinical-pipeline-licensed-gmp Health Bulletin Haiti en PressRelease 2026-04-29T12:58:51+00:00 XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies https://ml.globenewswire.com/media/c90a3187-c398-47d6-a46e-5d3647374681/small/logo-png.png https://www.healthbulletinhaiti.com/article/909026761-autonomix-medical-announces-abstract-acceptance-at-digestive-disease-week-2026-showcasing-long-term-data-in-pancreatic-cancer-pain-mitigation Health Bulletin Haiti en PressRelease 2026-04-29T12:45:00+00:00 Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation https://ml.globenewswire.com/media/8b0ba1bc-43b1-4445-b895-712da30f7df8/small/logo-png.png https://www.healthbulletinhaiti.com/article/909026785-renovorx-to-host-first-quarter-2026-financial-results-and-business-highlights-conference-call-on-may-14th-at-4-30-pm-et Health Bulletin Haiti en PressRelease 2026-04-29T12:30:00+00:00 RenovoRx to Host First Quarter 2026 Financial Results and Business Highlights Conference Call on May 14th at 4:30 pm ET https://ml.globenewswire.com/media/e18bf823-ff44-4bbd-82b9-3a311d58dad8/small/final-logo-horizontal-png.png https://www.healthbulletinhaiti.com/article/909026835-imviva-biotech-to-present-clinical-data-from-ongoing-phase-1-2-study-of-cta313-at-the-american-society-of-gene-cell-therapy-s-annual-meeting Health Bulletin Haiti en PressRelease 2026-04-29T12:30:00+00:00 Imviva Biotech to Present Clinical Data from Ongoing Phase 1/2 Study of CTA313 at the American Society of Gene & Cell Therapy's Annual Meeting https://ml.globenewswire.com/media/ZTM4OTJmYWUtMjBkNy00MTliLWE4YWUtZDdkYTE3ZWY5ZTlmLTEzMTkxMjUtMjAyNi0wNC0yOS1lbg==/tiny/Imviva-US-Holdings-LLC.png https://www.healthbulletinhaiti.com/article/909026866-inaugural-laudio-ashhra-report-reveals-how-hr-leaders-can-strengthen-workforce-stability-through-frontline-leadership Health Bulletin Haiti en PressRelease 2026-04-29T12:30:00+00:00 Inaugural Laudio-ASHHRA Report Reveals How HR Leaders Can Strengthen Workforce Stability Through Frontline Leadership https://ml.globenewswire.com/media/M2FhNjFjMzEtMWMzOS00NTZjLTkwYTUtNTU4MzhjYmQ2YTcwLTEyMDA5MjYtMjAyNi0wNC0yOS1lbg==/tiny/Ascend-Learning-Inc-.png https://www.healthbulletinhaiti.com/article/909026939-nuwellis-highlights-case-study-featuring-precision-ultrafiltration-therapy-in-pediatric-cardiorenal-care-at-ishlt-2026-annual-meeting Health Bulletin Haiti en PressRelease 2026-04-29T12:30:00+00:00 Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting https://ml.globenewswire.com/media/92c460b4-3e5c-4a6f-a33c-636a1520d076/small/nuwellis-logo-1-png.png https://www.healthbulletinhaiti.com/article/909026942-tomi-environmental-solutions-targets-70-billion-u-s-drone-and-defense-budget-with-autonomous-steramist-ihp-decontamination Health Bulletin Haiti en PressRelease 2026-04-29T12:30:00+00:00 TOMI Environmental Solutions Targets $70 Billion U.S. Drone and Defense Budget with Autonomous SteraMist iHP Decontamination https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthbulletinhaiti.com/article/909026906-laguna-announces-fda-clearance-of-ind-application-for-lgna-100-a-novel-t-cell-activator-for-high-risk-pediatric-leukemias Health Bulletin Haiti en PressRelease 2026-04-29T12:29:00+00:00 Laguna Announces FDA Clearance of IND Application for LGNA-100, a Novel γδ T Cell Activator for High-Risk Pediatric Leukemias https://ml.globenewswire.com/media/14da867a-1402-4d3d-b473-d3267f862b39/medium/mechanism-of-action-lgna-100-activated-t-cells-in-acute-mye.png https://www.healthbulletinhaiti.com/article/909020061-biomerica-s-infoods-ibs-data-accepted-for-presentation-at-digestive-disease-week-2026 Health Bulletin Haiti en PressRelease 2026-04-29T12:19:00+00:00 Biomerica’s inFoods® IBS Data Accepted for Presentation at Digestive Disease Week 2026 https://ml.globenewswire.com/media/3461b9f0-3e95-484f-96e9-71608fc20239/small/biomerica-png.png https://www.healthbulletinhaiti.com/article/909019727-candel-therapeutics-announces-commercialization-agreement-with-eversana-to-support-potential-u-s-launch-of-aglatimagene-besadenovec-in-localized Health Bulletin Haiti en PressRelease 2026-04-29T12:05:00+00:00 Candel Therapeutics Announces Commercialization Agreement with EVERSANA to Support Potential U.S. Launch of Aglatimagene Besadenovec in Localized Prostate Cancer https://ml.globenewswire.com/media/8b82e1e3-4a67-4472-a7c8-05f9d24c9bb0/small/candel-logo-fullcolor-4-png.png https://www.healthbulletinhaiti.com/article/909019979-sangamo-therapeutics-announces-transition-to-trading-on-otcqb-venture-market Health Bulletin Haiti en PressRelease 2026-04-29T12:05:00+00:00 Sangamo Therapeutics Announces Transition to Trading on OTCQB Venture Market https://ml.globenewswire.com/media/e3084490-aff3-4c15-8036-d94123563fd0/small/sangamo-logotm-11-11zon-png.png https://www.healthbulletinhaiti.com/article/909019585-cmr-surgical-submits-510-k-application-to-u-s-fda-to-expand-versius-plus-into-gynecology Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 CMR Surgical Submits 510(k) Application to U.S. FDA to Expand Versius Plus™ into Gynecology https://ml-eu.globenewswire.com/media/7001badd-03d7-4277-b46a-b06118c423cd/small/cmrsurgical-logo-rgb-hi-res-jpg.jpg https://www.healthbulletinhaiti.com/article/909019623-taysha-gene-therapies-to-release-first-quarter-2026-financial-results-and-host-conference-call-and-webcast-on-may-6 Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Taysha Gene Therapies to Release First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 6 https://ml.globenewswire.com/media/a88cd5f5-0b05-416c-a56b-e4130c10cfca/small/new-taysha-inline-fullcolor-rgb-12in-300ppi-jpg.jpg https://www.healthbulletinhaiti.com/article/909019625-electrocore-to-announce-first-quarter-march-31-2026-financial-results-on-wednesday-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026 https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://www.healthbulletinhaiti.com/article/909019635-rein-therapeutics-provides-clinical-trial-update-for-phase-2-renew-study-of-lti-03-in-idiopathic-pulmonary-fibrosis Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Rein Therapeutics Provides Clinical Trial Update for Phase 2 RENEW Study of LTI-03 in Idiopathic Pulmonary Fibrosis https://ml.globenewswire.com/media/7012d0d8-d19b-4f82-be65-c10f3701019b/small/logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909019648-picard-medical-syncardia-featured-in-interview-series-with-the-mullings-group Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Picard Medical / SynCardia Featured in Interview Series with The Mullings Group https://ml.globenewswire.com/media/93c733bb-b54a-41af-856b-6d01c1f724a2/small/syncardia-x-picard-email-signature-2025-1-png.png https://www.healthbulletinhaiti.com/article/909019660-brainsway-to-report-first-quarter-2026-financial-results-on-may-13-2026 Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 BrainsWay to Report First Quarter 2026 Financial Results on May 13, 2026 https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909019666-urogen-pharma-to-report-first-quarter-2026-financial-results-on-wednesday-may-6th-2026 Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 UroGen Pharma to Report First Quarter 2026 Financial Results on Wednesday, May 6th, 2026 https://ml.globenewswire.com/media/8b4e2813-5822-438f-a0d8-1a2c99628858/small/urogen-logo2-r-002-png.png https://www.healthbulletinhaiti.com/article/909019670-oryzon-to-participate-in-upcoming-events-in-may-and-june Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 ORYZON to Participate in Upcoming Events in May and June https://ml.globenewswire.com/media/56e13ce4-e7d9-45ee-85e9-26feec9b7c6f/small/logo-png.png https://www.healthbulletinhaiti.com/article/909019680-dlh-to-announce-fiscal-2026-second-quarter-financial-results Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 DLH to Announce Fiscal 2026 Second Quarter Financial Results https://ml.globenewswire.com/media/4efe5f34-0462-4275-ac88-2c8a07c2a9b0/small/dlh-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909019773-ultragenyx-to-host-conference-call-for-first-quarter-2026-financial-results-and-corporate-update Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Ultragenyx to Host Conference Call for First Quarter 2026 Financial Results and Corporate Update https://ml.globenewswire.com/media/121a9bda-7a64-41f8-85e8-1693a2dfa977/small/ultragenyx-cmyk-png.png https://www.healthbulletinhaiti.com/article/909019895-inspire-medical-systems-inc-to-present-at-the-bofa-securities-2026-healthcare-conference Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/194e83a5-3f7e-4805-88ce-da2e0ab594df/small/inspire-primary-logo-rgb-daylight-002-png.png https://www.healthbulletinhaiti.com/article/909019958-ontario-building-code-review-points-to-a-clear-win-for-families-and-future-homeowners-prevent-lung-cancer-cases-by-keeping-radon-mitigation-measures Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Ontario Building Code Review Points to a Clear Win for Families and Future Homeowners: Prevent Lung Cancer Cases by Keeping Radon Mitigation Measures in Place https://ml.globenewswire.com/media/58a138ed-9f59-4520-98a9-1e68ebed4f05/small/lhf-primarylogo-rgb-150dpi-002-orig-png.png https://www.healthbulletinhaiti.com/article/909019967-calidi-biotherapeutics-announces-strategic-partnership-with-transferai-to-drive-efficiencies-in-the-ind-submission-process-for-cld-401-using-agentic Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI https://ml.globenewswire.com/media/9e574b79-be62-4805-a4b4-cb0b7dcc5fbd/small/calidibiotherapeutics-logo-2x-jpg.jpg https://www.healthbulletinhaiti.com/article/909019973-beacon-therapeutics-annouces-presentations-at-the-arvo-2026-annual-meeting Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Beacon Therapeutics Annouces Presentations at the ARVO 2026 Annual Meeting https://ml.globenewswire.com/media/020367be-8998-4af7-93ce-7c0c06f88bcd/small/beacon-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909020022-tempest-to-advance-dual-targeting-car-t-platform-with-clinical-update-at-isct-2026-annual-meeting Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting https://ml.globenewswire.com/media/6ddb04fb-e5ac-416b-b90b-b4cbf51dc538/small/blue-logo-stacked-jpg.jpg https://www.healthbulletinhaiti.com/article/909020117-cortec-s-brain-interchange-bci-system-enables-stroke-patient-to-control-computer-with-his-mind Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 CorTec's Brain Interchange™ BCI System Enables Stroke Patient to Control Computer with his Mind https://ml.globenewswire.com/media/b24bcd60-c029-415f-bcfd-277fade5e278/small/cortec-logo-tm-sub-rgb-transp-png.png https://www.healthbulletinhaiti.com/article/909020132-tacalyx-secures-11-million-to-advance-lead-taca-targeting-adc-programme-toward-the-clinic Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic https://ml.globenewswire.com/media/7a78b3c0-b303-498d-abc4-fb965e97c7ec/small/2024-tacalyx-logo-442x134-png.png https://www.healthbulletinhaiti.com/article/909020134-gh-research-announces-pricing-of-117-5-million-underwritten-offering Health Bulletin Haiti en PressRelease 2026-04-29T12:00:00+00:00 GH Research Announces Pricing of $117.5 Million Underwritten Offering https://ml.globenewswire.com/media/a1baa9e5-3408-4f8f-b4aa-7c4204e0971b/small/full-colour-png.png https://www.healthbulletinhaiti.com/article/909012353-emergent-biosolutions-secures-long-term-strategic-manufacturing-contract-with-sab-biotherapeutics-to-advance-type-1-diabetes-candidate-sab-142 Health Bulletin Haiti en PressRelease 2026-04-29T11:35:00+00:00 Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142 https://ml.globenewswire.com/media/56a9097d-af91-4bcf-8c42-5905e1614ef1/small/emerge-png.png https://www.healthbulletinhaiti.com/article/909012305-cronos-group-inc-to-hold-virtual-2026-annual-meeting-of-shareholders Health Bulletin Haiti en PressRelease 2026-04-29T11:30:00+00:00 Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders https://ml.globenewswire.com/media/68e2d88b-b8e0-404a-995d-415a33773982/small/cronos-wm-black-logo-2-2-jpg.jpg https://www.healthbulletinhaiti.com/article/909012320-anika-reports-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-04-29T11:05:00+00:00 Anika Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/342e50d9-f0e4-4e79-b568-840299c2045d/small/anika-new-logo-blue-1200x628-png.png https://www.healthbulletinhaiti.com/article/909012340-corvel-corporation-launches-corvel-connected-an-ai-powered-claims-intelligence-layer-embedded-in-caremc Health Bulletin Haiti en PressRelease 2026-04-29T11:05:00+00:00 CorVel Corporation Launches CorVel Connected™, an AI-Powered Claims Intelligence Layer Embedded in CareMC® https://ml.globenewswire.com/media/dc150059-2d36-47de-9f10-e6f5990ba046/small/corvel-primary-full-color-png.png https://www.healthbulletinhaiti.com/article/909005174-ocugen-to-host-conference-call-on-tuesday-may-5-at-8-30-a-m-et-to-discuss-business-updates-and-first-quarter-2026-financial-results Health Bulletin Haiti en PressRelease 2026-04-29T11:02:00+00:00 Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/18d074ba-efcd-41fd-94bc-e3bf2cc4069d/small/ocugen-4c-logo-002-png.png https://www.healthbulletinhaiti.com/article/909004923-teva-delivers-strong-q1-2026-results-driven-by-innovative-portfolio-growth-and-disciplined-execution Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 Teva Delivers Strong Q1 2026 Results Driven by Innovative Portfolio Growth and Disciplined Execution https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.healthbulletinhaiti.com/article/909004977-okyo-ceo-and-cso-to-present-and-leadership-team-to-participate-at-upcoming-scientific-conferences-in-may Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May https://ml.globenewswire.com/media/23e4046d-dcf9-4dd1-945e-461e98a27d15/small/full-logo-okyo-jpg.jpg https://www.healthbulletinhaiti.com/article/909004982-adma-biologics-to-report-first-quarter-2026-financial-results-on-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 ADMA Biologics to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/468b61b4-73b9-495e-a4be-f4823782b2fd/small/adma-biologics-rgb-l-092115p-jpg.jpg https://www.healthbulletinhaiti.com/article/909004990-eyepoint-to-report-first-quarter-2026-financial-results-on-may-6-2026 Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026 https://ml.globenewswire.com/media/3934240c-3155-4c7d-a525-885791fdab8b/small/eypoint-new-reg-vertical-3c-rgb1-jpg.jpg https://www.healthbulletinhaiti.com/article/909005132-vitalhub-announces-q1-2026-conference-call-date Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 VitalHub Announces Q1 2026 Conference Call Date https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://www.healthbulletinhaiti.com/article/909005179-denovo-announces-issuance-of-u-s-patent-of-novel-genetic-biomarker-ank3-dgm4-for-liafensine-db104 Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 Denovo Announces Issuance of U.S. Patent of Novel Genetic Biomarker ANK3 (DGM4™) for Liafensine (DB104) https://ml.globenewswire.com/media/9e0ac0ad-5d34-4de9-a330-69131a9e6a27/small/denovo-logo-png.png https://www.healthbulletinhaiti.com/article/909005182-ocular-therapeutix-announces-first-patient-enrolled-in-sol-x-long-term-extension-trial-for-axpaxli-in-wet-amd Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 Ocular Therapeutix™ Announces First Patient Enrolled in SOL-X Long-Term Extension Trial for AXPAXLI™ in Wet AMD https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909005196-tonix-pharmaceuticals-announces-presentation-of-phase-1-data-and-plans-for-an-adaptive-phase-2-field-study-of-tnx-4800-anti-borrelia-ospa-monoclonal Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Plans for an Adaptive Phase 2 Field Study of TNX-4800 (anti-Borrelia OspA monoclonal antibody) for the Prevention of Lyme Disease at the 4th Annual Ticks and Tickborne Diseases Symposium… https://ml.globenewswire.com/media/16aad249-3d33-4501-b3d9-118a703fa46e/small/tonix2-jpg.jpg https://www.healthbulletinhaiti.com/article/909005293-amarin-reports-2026-first-quarter-financial-results Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 Amarin Reports 2026 First Quarter Financial Results https://ml.globenewswire.com/media/00eeab93-e634-4279-86b3-7973c2a21623/small/amarin-logo-jpeg-jpg.jpg https://www.healthbulletinhaiti.com/article/909005342-intellia-therapeutics-announces-pricing-of-public-offering-of-common-stock Health Bulletin Haiti en PressRelease 2026-04-29T11:00:00+00:00 Intellia Therapeutics Announces Pricing of Public Offering of Common Stock https://ml.globenewswire.com/media/9b6b17bb-c8a4-4009-b5f8-8cadb4d2296a/small/intellia-jpg.jpg https://www.healthbulletinhaiti.com/article/909005377-emergent-biosolutions-partners-with-professional-baseball-player-davis-schneider-to-raise-awareness-of-narcan-nasal-spray-among-canadians-and-help Health Bulletin Haiti en PressRelease 2026-04-29T10:53:56+00:00 Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help Save Lives https://ml.globenewswire.com/media/bc0caa11-9c65-478b-a405-4636dbd93f22/medium/emergent-biosolutions-partners-with-professional-baseball-pl.jpg https://www.healthbulletinhaiti.com/article/909004885-teva-to-acquire-emalex-biosciences-adding-nda-ready-first-in-class-therapy-to-neuroscience-pipeline-and-accelerating-teva-s-pivot-to-growth-strategy Health Bulletin Haiti en PressRelease 2026-04-29T10:30:00+00:00 Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.healthbulletinhaiti.com/article/909005156-regeneron-reports-first-quarter-2026-financial-and-operating-results Health Bulletin Haiti en PressRelease 2026-04-29T10:30:00+00:00 Regeneron Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthbulletinhaiti.com/article/909005189-agios-reports-first-quarter-2026-financial-results-and-provides-business-update Health Bulletin Haiti en PressRelease 2026-04-29T10:30:00+00:00 Agios Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/c7d64dad-71c8-47cc-a58d-c93a49ce8f01/small/agios-2021-logo-png.png https://www.healthbulletinhaiti.com/article/908997446-boehringer-ingelheim-and-eko-health-inc-launch-new-ai-based-solution-that-detects-heart-murmurs-in-dogs Health Bulletin Haiti en PressRelease 2026-04-29T10:00:00+00:00 Boehringer Ingelheim and Eko Health Inc. launch new AI-based solution that detects heart murmurs in dogs https://ml-eu.globenewswire.com/media/f121dfae-77e7-4a01-b1ef-6b757767ddab/small/111boehringer-ingelheim-logo-rgb-dark-green-002-png.png https://www.healthbulletinhaiti.com/article/908997588-kestra-medical-technologies-to-present-at-the-bofa-securities-2026-healthcare-conference Health Bulletin Haiti en PressRelease 2026-04-29T10:00:00+00:00 Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference https://ml.globenewswire.com/media/88c5ad8d-436a-4085-8905-f884861df934/small/kestra-medical-technologies-1200x628-3-jpg.jpg https://www.healthbulletinhaiti.com/article/908997602-hutchmed-announces-nda-acceptance-in-china-with-priority-review-status-and-breakthrough-designation-for-sovleplenib-for-the-treatment-of-warm-antibody Health Bulletin Haiti en PressRelease 2026-04-29T10:00:00+00:00 HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia https://ml.globenewswire.com/media/085957ad-3bec-49ee-b13e-39961b83c7be/small/hutchmed-small-spaced-1000x305-whitebgd-png.png https://www.healthbulletinhaiti.com/article/908960044-enterobiotix-secures-19m-to-initiate-phase-2b-clinical-trial-for-irritable-bowel-syndrome Health Bulletin Haiti en PressRelease 2026-04-29T07:00:00+00:00 EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome https://ml-eu.globenewswire.com/media/53e5896a-527b-4c54-aa1d-50c6f83f4332/small/enterobiotix-logo-r-colour-wb-rgb-png.png